Cardiovascular Sciences (CVSC) Stock Overview

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. More details

CVSC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($2K)

Latest financial reports are more than a year old

Shares are highly illiquid

CVSC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Cardiovascular Sciences, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cardiovascular Sciences
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-75.00%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CVSC	US Medical Equipment	US Market
7D	0%	-1.8%	-1.3%
1Y	n/a	-11.0%	10.9%

Return vs Industry: Insufficient data to determine how CVSC performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how CVSC performed against the US Market.

Price Volatility

Is CVSC's price volatile compared to industry and market?
CVSC volatility
CVSC Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.7%
Market Average Movement	6.4%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: CVSC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CVSC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Larry Hooper	www.cvsciences.org

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Catheters. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 2006.

Cardiovascular Sciences, Inc. Fundamentals Summary

How do Cardiovascular Sciences's earnings and revenue compare to its market cap?
CVSC fundamental statistics
Market cap	US$1.78k
Earnings (TTM)	US$218.97k
Revenue (TTM)	US$256.68k

0.0x

P/E Ratio

0.0x

P/S Ratio

Is CVSC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVSC income statement (TTM)
Revenue	US$256.68k
Cost of Revenue	US$0
Gross Profit	US$256.68k
Other Expenses	US$37.71k
Earnings	US$218.97k

Last Reported Earnings

Mar 31, 2009

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CVSC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/16 08:03
End of Day Share Price	2026/02/02 00:00
Earnings	2009/03/31
Annual Earnings	2008/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiovascular Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.